NeoNeuro has received a new grant from BPIfrance Financement, CMI- Amorcage 2 to continue our research towards the development of aptamers as diagnostic and therapeutic tools for Alzheimer’s disease.
NeoNeuro has received a new grant from BPIfrance Financement, CMI- Amorcage 2 to continue our research towards the development of aptamers as diagnostic and therapeutic tools for Alzheimer’s disease.